Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfluramine as antiepileptic in Dravet syndrome
2011-004114-42Phase 3Completed
- Sponsor
- Antwerp University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fenfluramine in Dravet syndrome and epilepsy, sponsored by Antwerp University Hospital. Primary endpoint: Seizure freedom. Started Apr 2021; status: completed.
02
Drugs
fenfluramine
03
Conditions
Dravet syndromeepilepsy
Beyond the preview
Go deeper on 2011-004114-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004114-42.